PRMT6 and glioblastoma: The prognostic significance of PRMT6 expression in patients with MES-subtype glioblastoma was then analyzed, and the results revealed that patients with elevated PRMT6 levels exhibited a poorer overall survival outcome in comparison to those with low PRMT6 expression (Fig. 1C, D).